Your browser doesn't support javascript.
loading
Perforation and Fistula of the Gastrointestinal Tract in Patients With Necrotizing Pancreatitis: A Nationwide Prospective Cohort.
Timmerhuis, Hester C; van Dijk, Sven M; Hollemans, Robbert A; Umans, Devica S; Sperna Weiland, Christina J; Besselink, Marc G; Bouwense, Stefan A W; Bruno, Marco J; van Duijvendijk, Peter; van Eijck, Casper H J; Issa, Yama; Mieog, J Sven D; Molenaar, I Quintus; Stommel, Martijn W J; Bollen, Thomas L; Voermans, Rogier P; Verdonk, Robert C; van Santvoort, Hjalmar C.
Afiliação
  • Timmerhuis HC; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • van Dijk SM; Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hollemans RA; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam GastroAQ2 enterology Endocrinology Metabolism, The Netherlands.
  • Umans DS; Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sperna Weiland CJ; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Besselink MG; Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, The Netherlands.
  • Bouwense SAW; Department of Research and Development, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Bruno MJ; Department of Gastroenterology and Hepatology, Radboud UMC, Nijmegen, The Netherlands.
  • van Duijvendijk P; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam GastroAQ2 enterology Endocrinology Metabolism, The Netherlands.
  • van Eijck CHJ; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
  • Issa Y; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Mieog JSD; Department of Surgery, Gelre Hospital, Apeldoorn, The Netherlands.
  • Molenaar IQ; Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Stommel MWJ; Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam GastroAQ2 enterology Endocrinology Metabolism, The Netherlands.
  • Bollen TL; Department of Surgery, Gelre Hospital, Apeldoorn, The Netherlands.
  • Voermans RP; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Verdonk RC; Department of Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Santvoort HC; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
Ann Surg ; 278(2): e284-e292, 2023 08 01.
Article em En | MEDLINE | ID: mdl-35866664
ABSTRACT

OBJECTIVE:

The aim of this study was to explore the incidence, risk factors, clinical course and treatment of perforation and fistula of the gastrointestinal (GI) tract in a large unselected cohort of patients with necrotizing pancreatitis.

BACKGROUND:

Perforation and fistula of the GI tract may occur in necrotizing pancreatitis. Data from large unselected patient populations on the incidence, risk factors, clinical outcomes, and treatment are lacking.

METHODS:

We performed a post hoc analysis of a nationwide prospective database of 896 patients with necrotizing pancreatitis. GI tract perforation and fistula were defined as spontaneous or iatrogenic discontinuation of the GI wall. Multivariable logistic regression was used to explore risk factors and to adjust for confounders to explore associations of the GI tract perforation and fistula on the clinical course.

RESULTS:

A perforation or fistula of the GI tract was identified in 139 (16%) patients, located in the stomach in 23 (14%), duodenum in 56 (35%), jejunum or ileum in 18 (11%), and colon in 64 (40%). Risk factors were high C-reactive protein within 48 hours after admission [odds ratio (OR) 1.19; 95% confidence interval (CI) 1.01-1.39] and early organ failure (OR 2.76; 95% CI 1.78-4.29). Prior invasive intervention was a risk factor for developing a perforation or fistula of the lower GI tract (OR 2.60; 95% CI 1.04-6.60). While perforation or fistula of the upper GI tract appeared to be protective for persistent intensive care unit-admission (OR 0.11, 95% CI 0.02-0.44) and persistent organ failure (OR 0.15; 95% CI 0.02-0.58), perforation or fistula of the lower GI tract was associated with a higher rate of new onset organ failure (OR 2.47; 95% CI 1.23-4.84). When the stomach or duodenum was affected, treatment was mostly conservative (n=54, 68%). Treatment was mostly surgical when the colon was affected (n=38, 59%).

CONCLUSIONS:

Perforation and fistula of the GI tract occurred in one out of six patients with necrotizing pancreatitis. Risk factors were high C-reactive protein within 48 hours and early organ failure. Prior intervention was identified as a risk factor for perforation or fistula of the lower GI tract. The clinical course was mostly affected by involvement of the lower GI tract.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Trato Gastrointestinal Superior / Fístula / Perfuração Intestinal Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Trato Gastrointestinal Superior / Fístula / Perfuração Intestinal Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article